Middle East Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027

Growth Outlook

• The 2027 portion of the Middle East Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 1698 Mn in 2026 and is projected to reach USD 1848 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
• By 2027, Anti-Infectives alone is expected to reach USD 599 Mn, with Others at USD 472 Mn.

Market Dynamics

The Middle East Companion Animal Healthcare Market has been witnessing a significant surge in demand for pharmaceuticals in recent years. This demand is primarily fueled by the growing awareness about the importance of animal healthcare and the increasing pet ownership in the region. According to a report by Grand View Research, the Middle East Companion Animal Healthcare Market is projected to reach USD million by 2027, registering a CAGR of % during the forecast period.

One of the major factors driving the demand for pharmaceuticals in the Middle East Companion Animal Healthcare Market is the rise in the number of pet owners. People in the region are becoming more conscious about their pets' health and are willing to spend on their well-being. This has led to an increase in the demand for companion animal healthcare products, including pharmaceuticals. As pets become an integral part of families in the Middle East, the demand for high-quality and effective healthcare products is expected to rise.

Another major factor contributing to the growth of the pharmaceutical segment in the Middle East Companion Animal Healthcare Market is the increasing prevalence of diseases among companion animals. The region has seen a rise in the incidence of diseases such as obesity, cancer, and arthritis in pets, which has led to an increase in the demand for pharmaceuticals for their treatment. Moreover, the growing prevalence of zoonotic diseases, which can be transmitted from animals to humans, has also led to an increased focus on animal health, driving the demand for pharmaceuticals in the market.

The Middle East Companion Animal Healthcare Market is also witnessing a shift towards preventive healthcare measures. Pet owners are increasingly seeking products that can help prevent diseases and maintain the overall health of their pets. This has led to a rise in demand for pharmaceuticals such as vaccines, preventives, and supplements, which are essential for maintaining the well-being of companion animals.

In addition to these factors, the development of new and improved pharmaceuticals, along with the rising disposable income in the region, are also expected to drive the demand for pharmaceuticals in the Middle East Companion Animal Healthcare Market. However, high costs associated with these products and the lack of awareness about animal health in certain regions may restrain the growth of the pharmaceutical segment in the Middle East Companion Animal Healthcare Market.